SEC Form 4 · accession 0001571049-15-010110
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
BFI Co., LLC
10% Owner
Period of report
Dec 16, 2015
Accepted (ET)
Dec 18, 2015 · 9:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Dec 16, 2015 | C | 12,000 | — | A | 78,000 | D | |
| Class A Common StockF2,F3 | Dec 16, 2015 | S | 4,000 | $32.07 | D | 74,000 | D | |
| Class A Common StockF2,F4 | Dec 17, 2015 | S | 4,000 | $31.69 | D | 70,000 | D | |
| Class A Common StockF2,F5 | Dec 18, 2015 | S | 4,000 | $31.72 | D | 66,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common StockF1 | — | Dec 16, 2015 | C | 12,000 | D | — | — | Class A Common Stock | 12,000 | 20,971,811 | D |
Explanation of responses
- F1The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2015.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.57 to $32.56, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.44 to $32.29, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.94 to $32.12, inclusive.